Thejus Jayakrishnan, Hematology/Oncology Fellow at Cleveland Clinic, shared a post by James Cleary, Gastrointestinal Oncologist at Dana-Farber Cancer Institute, shared on X:
“Thank you James Cleary for the opportunity to work on the review with you!”
Quoting James Cleary’s post:.
“Thejus Jayakrishnan did a wonderful job with this review on immunotherapy in anal cancer. While a subset of patients have long-term responses to PD1i, most are resistant.
New therapeutic approaches, and efforts to develop biomarkers, gives hope for the future.”
Source: Thejus Jayakrishnan/X and James Cleary/X